Stay Informed: Transforming Radiology with Structured Reporting and Data-Driven Approaches

Dive into our activities, projects, and product updates. Catch on the latest industry news and learn who we are as a company and as a team.

Recording of RSNA 2019 AI theater presentation | Power food for AI

At this year’s RSNA, Mint Medical presented its AI approach to the audience at the AI theater. Tobias Gottmann and Aditya Jayaram highlighted how every radiological read can contribute to an AI-powered future by seeding power food for AI.

Having mint Lesion in place, structured longitudinally connected image and reporting data will be captured for different oncological reading tasks. Those data could be used to empower personalized medicine, clinical decision support systems and to train and improve machine learning based algorithms.

Please find the recording of our AI theater presentation here: https://www.youtube.com/watch?v=Jo_NJRH1KFU&feature=youtu.be

Data Visualization Personalized Therapy Structured Reporting Data Collection Data Analysis AI

Related Resources

Related Resources

RECIST measurements of a patient with uveal melanoma and hepatic metastases

University Hospital Tuebingen: Study compares the Efficacy of SIRT and CS-PHP in Uveal Melanoma with Hepatic Metastasis

A study[1] conducted by researchers at University Hospital Tuebingen retrospectively compared the efficacy of two liver-targeted therapies,…

Study Analyzing the Tumor Growth Rate as a Prognostic Biomarker in Lymphoma Patients Under CAR T-Cell Therapy

University Hospital Munich (LMU): Study Analyzing the Tumor Growth Rate as a Prognostic Biomarker in Lymphoma Patients Under CAR T-Cell Therapy

A recent study[1] conducted by researchers at the University Hospital Munich (LMU) investigated the role of tumor growth rate (TGR) in predicting the…

A picture of a person looking at a brain scan and the interface of mint Lesion™ on a computer

Advancing Neuro-Oncology Assessments: Mint Medical to Integrate Newly Published RANO 2.0 Criteria into mint Lesion™

Glioblastomas and other gliomas are the most common malignant primary brain tumor types, yet few effective therapies are available. Clinical research…